The enterprise is an international high-tech entity driven by innovation in the field of medical devices R&D, production, and sales. It focuses on the diagnosis of microorganisms, tumors, and rare diseases, primarily engaged in the research and development of in vitro diagnostic reagents and automatic instruments.

The organization operates two R&D centers in China and the US, maintaining independent intellectual property rights for advanced technologies including fluorescent staining, protein labeling, and time-resolved immunofluorescence detection. The facilities include over 10,000 square meters of GMP purification production workshops that meet FDA, CE, and CFDA product standards.

With a global workforce where R&D personnel account for over 50%, the technical team is led by doctoral experts from prestigious institutions such as Osaka University, North Carolina University, and Zhejiang University, specializing in immunology, microbiology, and medical imaging.